Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Ticks and Tick-Borne Diseases|June 29, 2026
Not all trophozoites are malaria: A case of babesiosis in a traveler from the USAAnna Barbiero, Lucia Graziani, Laura Povolo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 7, 2023
Combination regimen of nirmatrelvir/ritonavir and molnupiravir for the treatment of persistent SARS-CoV-2 infection: A case report and a scoping review of the literatureDavide Marangoni, Roberta Maria Antonello, Marco Coppi, et al.
Plos One|November 11, 2014
SPIDIA-RNA: second external quality assessment for the pre-analytical phase of blood samples used for RNA based analysesFrancesca Malentacchi, Mario Pazzagli, Lisa Simi, et al.
Tropical Medicine and Infectious Disease|June 25, 2025
Molecular Assays on Cutaneous Swabs as an Effective, Non-Invasive Diagnostic Technique for Cutaneous Leishmaniasis: Results from a Retrospective Study Conducted in ItalyAnna Barbiero, Andrea Aiello, Nunziata Ciccone, et al.
Infectious Disease Reports|June 1, 2022
Implementing Early Phase Treatments for COVID-19 in Outpatient Settings: Challenges at a Tertiary Care Center in Italy and Future OutlooksTommaso Manciulli, Filippo Lagi, Anna Barbiero, et al.
Clinical Chemistry|June 22, 2007
EQUAL-qual: a European program for external quality assessment of genomic DNA extraction and PCR amplificationClaudio Orlando, Paolo Verderio, Ronald Maatman, et al.
BMJ Open|November 10, 2025
Let's trace: Leishmaniasis in Tuscany (Italy), tracking, research, analysis and continuous evaluation - a retrospective study protocol on underreporting of human cases, geolocation and public health implicationsClaudia Cosma, Carla Maia, Guglielmo Bonaccorsi, et al.
Frontiers in Immunology|February 14, 2022
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including OmicronAlessio Mazzoni, Anna Vanni, Michele Spinicci, et al.
Pageof 5